← Back to headlines
Novo Nordisk Faces Challenge in Finding Next Blockbuster After Wegovy Success
Novo Nordisk, which became Europe's most valuable company thanks to its weight loss drug Wegovy, is now reportedly struggling to identify its next major blockbuster pharmaceutical.
6 Aug, 12:31 — 6 Aug, 12:31
